Welcome to our dedicated page for Life360 SEC filings (Ticker: LIF), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Life360, Inc. filings document regulatory disclosures for a Delaware technology company whose common stock trades on Nasdaq under LIF. Form 8-K reports furnish operating and financial results, Regulation FD presentation materials, material-event disclosures, material agreements, shareholder voting matters and capital-structure information.
Proxy materials describe board and executive compensation matters, equity awards, corporate governance and voting procedures. The filing record also reflects disclosure areas tied to Life360’s family safety platform, subscription metrics, advertising initiatives, legal and compliance oversight, and public-company securities reporting.
Life360, Inc. director Randi Zuckerberg reported an equity compensation grant in the form of 4,455 shares of common stock, structured as Restricted Stock Units (RSUs) granted at no cash cost per share. These RSUs vest over time, with one quarter of the award vesting quarterly from May 15, 2026, conditioned on her continued service. Following this award, she is shown as directly holding 29,532 shares of common stock, which the disclosure notes includes 5,134 RSUs that each convert into one share upon vesting or settlement.
Life360, Inc. director David Wiadrowski received a grant of 4,816 Restricted Stock Units (RSUs) of common stock at no cash cost. Each RSU represents the right to receive one share upon settlement.
One quarter of the RSUs will vest quarterly starting on May 15, 2026, subject to his continuous service through each vesting date. Following this award, he holds 44,495 shares of common stock in total, which includes 5,554 RSUs and common stock underlying Chess Depositary Interests (CDIs) converted using a 1:3 common stock-to-CDI ratio.
Synge James reported acquisition or exercise transactions in this Form 4 filing.
Life360, Inc. director James Synge received a grant of 4,600 restricted stock units (RSUs) of common stock on May 29, 2026. Each RSU represents a contingent right to one share of Life360 common stock, with one quarter of the award vesting quarterly from May 15, 2026, subject to his continuous service.
Following this grant, Synge directly holds 191,021 shares and RSUs in total, including 5,303 RSUs and shares underlying Chess Depositary Interests (CDIs) on the Australian Securities Exchange, which are convertible at a 1:3 common stock to CDI ratio.
Life360, Inc. director Charles J. Prober received a grant of 4,455 shares of common stock in the form of Restricted Stock Units (RSUs) on May 29, 2026 as equity compensation. The RSUs carry no purchase price and each represents the right to receive one share upon settlement.
According to the terms, one-quarter of the RSUs will vest quarterly starting from May 15, 2026, subject to his continued service through each vesting date. Following this award, Prober directly holds 109,911 shares of Life360 common stock, which includes 5,134 RSUs that each convert into one share upon vesting.
Life360, Inc. director Brit Morin received a grant of 4,636 Restricted Stock Units (RSUs), each representing a right to one share of common stock at no cash cost. One quarter of these RSUs will vest quarterly from May 15, 2026, assuming continued service. Following this award, Morin directly holds 30,630 shares and RSUs in total, which includes 5,345 RSUs that each convert into one share upon vesting.
Life360, Inc. director Alex Haro received a grant of 4,455 Restricted Stock Units (RSUs), each representing a right to receive one share of common stock upon settlement. The award was made at a price of $0.00 per share as equity compensation.
According to the filing, one-quarter of the RSUs will vest quarterly from May 15, 2026, conditioned on Haro’s continued service through each vesting date. After this grant, he holds 1,010,303 shares of common stock, which includes 5,134 RSUs that will convert into shares upon vesting.
Goines Mark reported acquisition or exercise transactions in this Form 4 filing.
Life360, Inc. director Mark Goines reported an equity compensation award and updated share holdings. He received a grant of 5,322 Restricted Stock Units (RSUs), each representing a contingent right to receive one share of common stock upon settlement, with one‑quarter vesting quarterly from May 15, 2026, subject to his continuous service.
After this grant, he holds 11,392 shares of common stock directly, which include 6,102 RSUs. He also reports 56,809 shares held indirectly through the Goines Wong Living Trust. The transactions reflect routine stock-based compensation and updated ownership rather than open-market buying or selling.
Life360, Inc. director John Philip Coghlan reported both equity awards and sales of common stock. He received a grant of 4,840 Restricted Stock Units at no cost, bringing his directly held RSUs to 5,676, which vest quarterly from May 15, 2026, subject to continued service. Through the John Coghlan Living Trust, he sold a total of 4,000 shares in open-market transactions at weighted average prices of about $43.95 and $44.64, executed under a pre-arranged Rule 10b5-1 trading plan adopted on December 8, 2025. After these sales, that trust holds 28,431 shares, while a separate Grantor Retained Annuity Trust holds 55,494 shares of common stock.
Life360 director Chris Hulls reported option exercises and share sales under a pre‑planned trading arrangement. On May 28, 2026, he exercised stock options for 27,000 shares of common stock at $8.19 per share and sold 16,379 shares in open‑market transactions at a weighted average price of $40.34 per share. The sale was executed pursuant to a Rule 10b5‑1 trading plan adopted in December 2025, meaning the trades followed predetermined criteria rather than discretionary timing.
After these transactions, the filing reports 419,864 shares of common stock held directly and 152,801 stock options remaining outstanding. It also shows 195,312 shares of common stock held indirectly in each of the McKenzie Hulls 2023 Irrevocable Trust, the Rose Hulls 2023 Irrevocable Trust, and the Robin Hulls 2023 Irrevocable Trust, along with 149,318 restricted stock units representing additional contingent rights to shares.
Life360, Inc. reported results of its annual stockholder meeting held on May 28, 2026. Stockholders representing 58,067,511 shares, or about 71.96% of the 80,689,686 shares outstanding as of April 9, 2026, were present, establishing a quorum.
Four Class I directors — Lauren Antonoff, Mark Goines, Alex Haro, and Randi Zuckerberg — were elected to serve until the 2029 annual meeting. Stockholders also approved, on an advisory and non-binding basis, the compensation of the named executive officers and ratified the appointment of Deloitte & Touche LLP as independent registered public accounting firm for 2026.